ArticlePlastic and reconstructive surgery. Global open2026
Nonvolumetric Indications for Fat Grafting in Breast Surgery and Breast Reconstruction: A Scoping Review.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Autologous fat grafting (AFG) has growing interest for its versatility and efficacy in breast reconstruction. This scoping review aims to summarize the evidence for nonvolumetric indications of AFG in breast surgery and breast reconstruction. Methods: MEDLINE, Embase, and Web of Science were searched from inception to March 2024. Articles were included if they used AFG in breast surgery for nonvolumetric indications. The primary outcome was the indication for AFG. Secondary outcomes included the capsular contracture (CC) rate, incidence of postmastectomy pain syndrome (PMPS), patient satisfaction, physician outcome measures, functional discomfort, and complications. A risk-of-bias assessment was performed. Results: After screening 7294 citations, 104 full-text articles were included. Indications included (1) CC; (2) PMPS; (3) contour deformities, asymmetry, and congenital deformities; (4) preparation of implant pocket; and (5) other indications. AFG is recommended for contour correction and congenital deformities. Pretreatment of radiated mastectomy flaps with AFG improved outcomes in implant-based breast reconstruction. Additional uses include gynecomastia, nipple reconstruction/sensation, and lymphedema. AFG did not significantly reduce CC rates overall (relative risk, 0.85 [0.62-1.17]; Conclusions: AFG shows promise for several emerging nonvolumetric breast applications in autologous and implant-based breast reconstruction. It may be a good adjunct in select patients, particularly those who have received radiation therapy.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.